Quipt Home Medical (QIPT) Expected to Announce Quarterly Earnings on Monday

Key Points

• Quipt Home Medical (QIPT) is set to release its Q3 2025 earnings on August 11th, with analysts predicting earnings of $0.03 per share and revenue of $80.37 million for the quarter.
• Following a previous earnings report in May where the company missed estimates, Quipt Home Medical saw its stock price reach $2.41, with market analysts reporting a mixed range of stock ratings.
• Institutional investors currently own 42.85% of Quipt's stock, and Jane Street Group recently acquired a new stake, indicating ongoing interest in the company's financial prospects.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) will likely be announcing its Q3 2025 earnings results after the market closes on Monday, August 11th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $80.37 million for the quarter.

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last announced its quarterly earnings data on Monday, May 12th. The company reported ($0.07) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.09). The company had revenue of $57.40 million for the quarter, compared to analyst estimates of $88.29 million. Quipt Home Medical had a negative net margin of 3.66% and a negative return on equity of 8.38%. On average, analysts expect Quipt Home Medical to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Quipt Home Medical Price Performance

NASDAQ QIPT traded up $0.01 on Friday, reaching $2.15. The company's stock had a trading volume of 37,200 shares, compared to its average volume of 537,448. Quipt Home Medical has a 52 week low of $1.35 and a 52 week high of $3.37. The company has a current ratio of 1.22, a quick ratio of 0.85 and a debt-to-equity ratio of 0.76. The business has a 50-day moving average price of $2.00 and a 200 day moving average price of $2.23. The firm has a market cap of $93.19 million, a PE ratio of -10.21 and a beta of 0.59.

Institutional Trading of Quipt Home Medical

An institutional investor recently raised its position in Quipt Home Medical stock. Kanen Wealth Management LLC increased its stake in Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) by 108.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,969,541 shares of the company's stock after purchasing an additional 1,544,529 shares during the period. Quipt Home Medical makes up 2.8% of Kanen Wealth Management LLC's holdings, making the stock its 12th largest position. Kanen Wealth Management LLC owned approximately 6.83% of Quipt Home Medical worth $6,919,000 as of its most recent filing with the Securities and Exchange Commission. 42.85% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on QIPT. Canaccord Genuity Group reissued a "hold" rating and issued a $1.70 price target (down previously from $4.00) on shares of Quipt Home Medical in a report on Tuesday, May 13th. Benchmark reaffirmed a "buy" rating and set a $4.00 price objective (down from $6.00) on shares of Quipt Home Medical in a research note on Wednesday, May 14th. Finally, Wall Street Zen lowered Quipt Home Medical from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.